Harvard Management CO Inc Praxis Precision Medicines, Inc. Transaction History

Harvard Management CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.83 - $1.18 $71,297 - $101,362	-85,900 Reduced 11.03%	692,617 $797,000
Q1 2021 May 07, 2021	SELL	$29.34 - $60.2 $413,694 - $848,820	-14,100 Reduced 1.78%	778,517 $25.5 Million
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $21.6 Million - $44.2 Million	792,617 New	792,617 $43.6 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $2.62B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Harvard Management CO Inc, based on Form 13F filings with the SEC.

Stay updated on Harvard Management CO Inc with notifications on news.